The biopharmaceutical contract biomanufacturing market is estimated to be worth USD 32.4 billion in

Driven by several blockbuster products, a burgeoning pipeline and the need for dedicated expertise in the myriad of technical nuances associated with biomolecules, the biopharmaceutical contract manufacturing market has a lucrative future

Roots Analysis is pleased to announce the publication of its recent study, titled, “ Biopharmaceutical Contract Biomanufacturing Market, (4th Edition), 2020-2030.”

The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analyses, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and contract development and manufacturing organizations (CDMOs). Amongst other elements, the report includes:
 A detailed review of the overall landscape of companies offering biopharmaceutical contract manufacturing services.
 A detailed landscape of the biopharmaceutical manufacturing facilities established across the key geographical regions.
 Elaborate profiles of key players that claim to have a diverse range of capabilities related to the development, manufacturing and packaging of biologics.
 A detailed discussion on the key enablers in this domain, including certain niche product classes, such as antibody drug conjugates (ADCs), bispecific antibodies, cell therapies, gene therapies and viral vectors.
 A case study on the growing global biosimilars market, highlighting the associated opportunities for biopharmaceutical CMOs and CDMOs.
 A case study comparing the key characteristics of small and large molecule drugs, along with details on the various steps involved in their respective manufacturing processes.
 A detailed discussion on the overview, benefits and challenges associated with in-house manufacturing.
 A qualitative analysis, highlighting the various factors that need to be taken into consideration by biopharmaceutical therapeutics / drug developers while deciding whether to manufacture their respective products in-house

Leave a Reply

Your email address will not be published. Required fields are marked *